---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-046010"
form_type: "8-K"
ticker: "CHRN"
cik: "0001549084"
company_name: "EKSO BIONICS HOLDINGS, INC."
filed_at: "2026-10-06T21:20:39+00:00"
generated_at: "2026-10-12T16:07:22.483936+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# ChronoScale director Scott Davis resigns after Ekso sale; gets $709,500 and 51,626 RSUs

## Summary
- Scott Davis, Ekso Bionics CEO and ChronoScale board member, resigned from the board effective October 3, 2026, with no disagreements cited; the Ekso sale closed September 30, 2026.
- Davis received 51,626 fully vested restricted stock units granted October 2, 2026, plus a $709,500 lump-sum cash payment payable within 30 days under a Release Agreement.
- The Release Agreement includes a general release of claims and stands in lieu of any payment under the Nov. 5, 2025 Change in Control and Severance Agreement; the Phantom RSU Agreement is unchanged.
- ChronoScale common stock trades on the Nasdaq Capital Market under CHRN; CFO Jerome Wong signed the report dated October 6, 2026.

## SEC filing metadata
- accession: 0001493152-26-046010
- form_type: 8-K
- ticker: CHRN
- cik: 0001549084
- company_name: EKSO BIONICS HOLDINGS, INC.
- filed_at: 2026-10-06T21:20:39+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1549084/000149315226046010/0001493152-26-046010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549084/000149315226046010/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-046010
- JSON: https://secwatch.observer/filing/0001493152-26-046010.json
- Plain text: https://secwatch.observer/filing/0001493152-26-046010.txt

## Key facts
- Executive change
  Scott Davis resigned as Member of the Board of Directors at EKSO BIONICS HOLDINGS, INC..
  - Action: resigned
  - Role: Member of the Board of Directors
  source text: Scott Davis, a member of the Board of Directors of the Company (the “Board”) and Chief Executive Officer (“CEO”) of Ekso, resigned from his position as a member of the Board, effective as of October 3, 2026. There were no disagreements between the Company and Mr. Davis that led to his decision to resign.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000149315226046010/0001493152-26-046010-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.